SFDA market accessResearch SFDA registration records, classification, regulations, timelines, fees, and market updates — the stable entrance to every Saudi Arabia medical device resource.
Search products in SFDA's official medical-equipment list.
Explore published classifications, listing status, and manufacturers in the official SFDA equipment list.
Browse official SFDA regulations and guidance documents.
Compare official and realistic approval times by device class and pathway.
Review current SFDA application, review, and renewal fees.
Estimate the likely SFDA pathway, government fees, dossier preparation time, review timeline, and registration steps.
Follow recent SFDA policy, guidance, and compliance updates.
Describe your device and get a preliminary SFDA risk class with an explanation and source links.
Check whether product features may trigger separate radio, electrical, metrology, radiation, import, or other Saudi Arabia requirements.
Describe a device and find comparable items in SFDA's official medical-equipment list.
Browse source-linked lifecycle, language, local-role, renewal, and change-control facts.
Common questions about changing a registered medical device in Saudi Arabia. Each question separates published rules from details still awaiting verification.
24 of 25 research dimensions currently covered · 19 official sources · latest verification 2026-10-21
SFDA registration fees in SAR · reviewed 2026-08-25
Saudi Food and Drug Authority (SFDA) review clocks and planning ranges · 4-class (A, B, C, D) classification
| Class / pathway | Review clock | Planning total | Provenance |
|---|---|---|---|
| Class A(MDMA Registration (Technical File Assessment)) SFDA publishes one lead time for every fee group in its MDMA evaluation fees table: 35 working days, from the lowest group (all Class I and general IVDs) to the highest. The FAQ repeats the same 35-business-day maximum without distinguishing risk class There is no separate low-risk listing route any more. The Medical Device National Registry, which let non-sterile non-measuring Class A devices be listed without a technical file or an Authorized Representative, was cancelled in September 2022 What Class A still gets is a lighter dossier, not a lighter process: MDS-REQ 1 item 4 cuts the submission for low-risk devices that are not IVDs, sterile, measuring, reusable surgical instruments or novel down to six elements — device description and specification, information provided by the manufacturer, essential principles checklist, evidence of compliance, risk management file, and post-market surveillance plan and report The abbreviated dossier is conditional: SFDA may demand the full technical documentation at any point, including after the MDMA has been granted, and it must be supplied within 10 days | 35 working days | 1.5-3 months | Verified |
| Class B(MDMA Registration) SFDA FAQ: the marketing authorization (MDMA) is issued within 35 business days as a maximum if all requirements are fulfilled Full technical file required since Jan 2022 | 35 working days | 1.5-3 months | Verified |
| Class C(MDMA Registration) SFDA FAQ: the marketing authorization (MDMA) is issued within 35 business days as a maximum if all requirements are fulfilled Clinical data may be required | 35 working days | 3-5 months | Verified |
| Class D(MDMA Registration) SFDA FAQ: the marketing authorization (MDMA) is issued within 35 business days as a maximum if all requirements are fulfilled Extensive clinical data required | 35 working days | 4-6 months | Verified |
Newest official SFDA headlines from the daily-refreshed feed — every row links directly to the authority publication.
Saudi ArabiaSep 6SFSFDASFDA Detects Misleading Claims in Medical Device Advertisement and Takes Legal ActionSaudi ArabiaSep 1SFSFDASFDA Launches Smart Verification Tool for Regulated Products at LEAP 2026Saudi ArabiaAug 19, 25SFSFDAGuidance on the Operation and Use of Radiation-Emitting Medical Devices (MDS–G007)Saudi ArabiaAug 19, 25SFSFDAGuidance Manual for Operating and Using Radiation-Emitting Medical Devices (MDS–G007)Saudi ArabiaOfficial SFDA rules and guidance · 17 of 17 documents linked to official sources
Computed from 106,115 official SFDA published listing entry records · data as of 2026-11-09
The target market is carried into each tool. Add the product, evidence, or regulatory change you want to assess.
Structure company, product, model, approval, certificate, and evidence facts before starting Saudi Arabia work.
Connect the SFDA route, evidence, labels, local role, timing, and dependencies to a wider launch plan.
Compare an existing authorization and evidence set against SFDA administrative, testing, labeling, and dossier needs.
Map a product or manufacturing change to SFDA evidence, notification, timing, and implementation questions.
Assess a current SFDA update against one product and turn it into an owner-ready action workpaper.
Review connected-device architecture, risks, SBOM, testing, lifecycle controls, and market-specific questions for Saudi Arabia (SFDA).
Algeria
Angola
Bahrain
Benin
Botswana
Burkina Faso
Burundi
Cabo Verde
Cameroon
Central African Republic
Chad
Comoros
Côte d'Ivoire
Democratic Republic of the Congo
Djibouti
Egypt
Equatorial Guinea
Eritrea
Eswatini
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Iran
Iraq
Israel
Jordan
Kenya
Kuwait
Lebanon
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Oman
Qatar
Republic of the Congo
Rwanda
Sao Tome and Principe
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Tanzania
Togo
Tunisia
Uganda
United Arab Emirates
Zambia
ZimbabweAll 156 markets →
